ESR1 and breast carcinoma: Here, we report the prognostic performance of the gene expression-based BCI within a clinical case series of patients with ER+ LN- breast cancer and demonstrate that BCI is a highly significant predictor of distant metastasis and death in patients treated with adjuvant tamoxifen, with or without chemotherapy.